HEC-1-A Cells
USD$395.00*
Products are shipped frozen on dry ice in cryotubes. Each cryotube typically contains 3 × 106 cells for adherent lines or 5 × 106 cells for suspension lines (refer to the batch CoA for details).
General information
| Description | HEC-1-A cells are a well-characterized human endometrial adenocarcinoma cell line derived from the malignant tissue of a 71-year-old Caucasian woman. This cell line, established in the mid-1970s, is extensively used in gynecological cancer research, particularly for studying endometrial carcinoma. Morphologically, HEC-1-A cells are epithelial-like and form a monolayer of polygonal cells when cultured. They exhibit a robust and adherent growth pattern, which is typical of epithelial cells originating from solid tumors. The morphological characteristics of HEC-1-A cells make them a valuable model for studying cellular behaviors that are central to cancer progression, such as adhesion, migration, and invasion. Genotypically, HEC-1-A cells harbor several genetic aberrations that are relevant to cancer biology, including mutations in key regulatory genes like p53 and PTEN, both of which are commonly mutated in endometrial cancer. These genetic features contribute to the cells' utility in researching the molecular underpinnings of endometrial carcinogenesis and the cellular pathways leading to tumor growth and resistance to therapy. Research using HEC-1-A cells has significantly advanced our understanding of endometrial cancer, particularly in terms of hormonal influences, genetic mutations, and responses to chemotherapeutic agents. As a result, this cell line continues to be instrumental in developing more effective diagnostic and therapeutic strategies for endometrial carcinoma. |
|---|---|
| Organism | Human |
| Tissue | Uterus, endometrium |
| Disease | Endometrial adenocarcinoma |
| Synonyms | Hec-1-A, HEC-1A, HEC1-A, HEC1A, Hec1A |
Characteristics
| Age | 71 years |
|---|---|
| Gender | Female |
| Ethnicity | Asian |
| Morphology | Epithelial |
| Growth properties | Adherent |
Regulatory Data
| Citation | HEC-1-A (Cytion catalog number 305077) |
|---|---|
| Biosafety level | 1 |
| NCBI_TaxID | 9606 |
| CellosaurusAccession | CVCL_0293 |
Biomolecular Data
| Receptors expressed | Receptor expression: platelet activating factor(PAF) |
|---|---|
| Protein expression | Oncogenes: C-Fos+ |
| Antigen expression | Blood Type B, Rh+ |
| Tumorigenic | Yes |
Handling
| Culture Medium | McCoys 5a, w: 3.0 g/L Glucose, w: stable Glutamine, w: 2.0 mM Sodium pyruvate, w: 2.2 g/L NaHCO3 (Cytion article number 820200a) |
|---|---|
| Supplements | Supplement the medium with 10% FBS |
| Dissociation Reagent | Accutase |
| Subculturing | Remove the old medium from the adherent cells and wash them with PBS that lacks calcium and magnesium. For T25 flasks, use 3-5 ml of PBS, and for T75 flasks, use 5-10 ml. Then, cover the cells completely with Accutase, using 1-2 ml for T25 flasks and 2.5 ml for T75 flasks. Let the cells incubate at room temperature for 8-10 minutes to detach them. After incubation, gently mix the cells with 10 ml of medium to resuspend them, then centrifuge at 300xg for 3 minutes. Discard the supernatant, resuspend the cells in fresh medium, and transfer them into new flasks that already contain fresh medium. |
| Fluid renewal | 2 to 3 times per week |
| Freeze medium | As a cryopreservation medium, we use complete growth medium (including FBS) + 10% DMSO for adequate post-thaw viability, or CM-1 (Cytion catalog number 800100), which includes optimized osmoprotectants and metabolic stabilizers to enhance recovery and reduce cryo-induced stress. |
| Thawing and Culturing Cells |
|
| Incubation Atmosphere | 37°C, 5% CO2, humidified atmosphere. |
| Shipping Conditions | Cryopreserved cell lines are shipped on dry ice in validated, insulated packaging with sufficient refrigerant to maintain approximately −78 °C throughout transit. On receipt, inspect the container immediately and transfer vials without delay to appropriate storage. |
| Storage Conditions | For long-term preservation, place vials in vapor-phase liquid nitrogen at about −150 to −196 °C. Storage at −80 °C is acceptable only as a short interim step before transfer to liquid nitrogen. |
Quality Control & Molecular Analysis
| Sterility | Mycoplasma contamination is excluded using both PCR-based assays and luminescence-based mycoplasma detection methods. To ensure there is no bacterial, fungal, or yeast contamination, cell cultures are subjected to daily visual inspections. |
|---|
Certificate of Analysis (CoA)
| Lot Number | Certificate Type | Date | Catalog Number |
|---|---|---|---|
| 305077-180123 | Certificate of Analysis | 23. May. 2025 | 305077 |